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. Alternative splicing at a latent 5' splice site is activated by start-codonmutations. (a) Schematic drawings of the wild-type CAD minigene construct (CAD-WT) and its start-codon-mutants (CAD-Mut31 and CAD-Mut70). Start codons (AUG) and the inframe stop codons are marked (S, designates a stop codon followed by a number that represents its distance in nucleotides from the authentic 5' splice site). Open boxes, exons; lines, introns; narrow boxes, latent exons; AUG mutations are underlined; diagonal lines indicate the expected splicing pattern for each construct. (b) HEK 293T cells were transfected with WT and mutant minigene constructs as indicated. Precursor and spliced RNAs were amplified by real-time RT-PCR using product-specific primer-pairs as indicated. The reverse (downstream) primer was common to all three pairs. The specific forward primer for pre-mRNA was derived from the intron, and the forward primers for authentic and latent mRNAs were derived from sequences that flank the junction between a sequence upstream of the respective 5' splice site and a sequence in the downstream exon (for further details see Materials and Methods and ref. 1) . Each PCR product was subjected to electrophoresis in 7.5% polyacrylamide/7M urea gels to confirm the production of a single amplicon per reaction. The block diagrams represent averages of three independent quantitative real-time RT-PCR experiments with bars indicating standard error (SE). The levels of latent mRNA compared to authentic mRNA are 0.4 and 0.1 percent for CAD Mut31 and CAD Mut 70, respectively. (Fig. S2) As a further control for the effect of mutant initiator-tRNAs on SOS we show that none of the three initiator-tRNA constructs had any effect on the splicing pattern of the pre-mRNA expressed from the CAD-WT construct. Fig. S2 . Mutant initiator-tRNAs do not induce latent splicing in WT CAD. Co-transfection of CAD-WT with wild-type or mutant initiator-tRNA constructs does not elicit latent splicing. HEK 293T cells, transfected with CAD-WT were cotransfected with plasmids expressing each of the three initiator-tRNAs, as indicated. Total RNA was analyzed by RT-PCR using a primer-pair that amplifies the 296-nt cDNA fragment that corresponds to CAD pre-mRNA and the 196-nt fragment that corresponds to the latent mRNA (schematically drawn on the left). Lane 4 is an RT-PCR analysis of RNA expressed from CAD-Mut9, a mutant lacking in frame stop codons, to mark the position of the band that corresponds to latent CAD mRNA.
Mutant initiator-tRNAs do not induce latent splicing in WT CAD
Anti-codon mutations in initiator-tRNA rescue SOS -The IDUA gene case (Fig. S3) To address the generality of the initiator-tRNA-induced rescue of SOS effect, analyses similar to those done for the CAD gene were carried out with the IDUA gene, using pre-mRNAs expressed from IDUA-WT and from IDUA-Mut30 -an AUG to AAA mutant thereof (Fig. S3a) . The intron of IDUA pre-mRNA has a strong latent 5'SS whose usage for splicing was shown to be suppressed by the single upstream in frame stop codon (2, 3); and Fig. S3b, gel, lane 1) . As expected, the AUG to AAA mutation in IDUA-Mut30 elicited latent splicing in this pre-mRNA (Fig. S3b, lane 2) . Quantitative real-time RT-PCR analyses of latent splicing and its rescue in IDUA pre-mRNA (Fig. S3c) , was then carried out in an analogous manner to that described for the CAD transcripts. It can be seen that in the presence of the mutant Met- RT-PCR analyses were performed using product-specific primer-pairs and the products were analyzed by denaturing gel electrophoresis (upper panels). The block diagrams represent averages of quantitative real-time RT-PCR results; error bars represent standard errors of three independent experiments. (d) Co-transfection of IDUA-WT with wild-type or mutant initiator-tRNA constructs does not elicit latent splicing. HEK 293T cells, transfected with IDUA-WT were cotransfected with plasmids expressing each of the three initiator-tRNAs, as indicated. Total RNA was analyzed by RT-PCR using a primer-pair that amplifies the 537-nt cDNA fragment that corresponds to IDUA pre-mRNA and the 206-nt fragment that corresponds to the latent mRNA (schematically drawn on the left). Lane 4 is an RT-PCR analysis of RNA expressed from IDUA-Mut2, a mutant lacking in frame stop codons, to mark the position of the band that corresponds to latent IDUA mRNA.
Charging state of mutant initiator tRNAs in rabbit reticulocyte lysate (Fig. S4) We further examined the charging state of the three initiator tRNAs in a rabbit reticulocyte cellfree system. The respective 32 P-labeled initiator tRNA transcripts were incubated in the lysate under conditions that promote translation. RNA was isolated and analyzed by gel electrophoresis in an acidic polyacrylamide gel as described (11) . Fig. S4 shows that, whereas the WT Met- S4 . The anti-codon mutants of initiator tRNA are not aminoacylated. Rabbit reticulocyte lysate was incubated with 32 P-labeled tRNAs as indicated for 1 h. Total RNA was isolated under acidic conditions and analyzed on a 6.5% polyacrylamide denaturing gel as described (11) . Sample in lanes 2,4,6 were deacylated by treatment at pH 8.8. Lane M, DNA size markers.
Mutant initiator-tRNAs abrogate NMD (Fig. S5)
Several lines of evidence presented here and elsewhere (1, 3) , have already suggested that SOS is an RNA proof-reading mechanism distinct from mammalian NMD and its known branches. Yet, a possibility still existed that the reduced levels of the latent PTC-containing mRNAs in cells transfected with the mutant initiator-tRNAs could have been attributed to the enhancement of NMD rather than to the rescue of SOS. This interpretation predicted that co-expression of mutant initiator-tRNAs would further down regulate the expression levels of bona fide PTC-containing mRNAs known to be subject to NMD.
We directly tested this prediction using two reporter constructs whose expressed mRNAs have been shown to be down-regulated by NMD: (i) CAD Ter -a mutant construct expressing CAD mRNA that contains a PTC in a bona fide exon (2); and (ii) the commonly used β-globin Ter39 -a mutant construct expressing β-globin mRNA having a PTC at codon 39 (4) . Fig. S5 shows that the levels of both reporter mRNAs expressed in the untreated cells (Fig. S5, lane 1) increased by about 2.6-fold after abrogating NMD by the protein synthesis inhibitor CHX (Fig.   S5, lane 2) . However, in contrast to the prediction made by the alternative interpretation, the levels of the reporter mRNAs in cells co-transfected with either of the mutated initiator-tRNAs (Fig. S5, lanes 4,5) increased by 3 to 4.2-fold relative to that expressed in cells co-transfected with the WT initiator-tRNA (Fig. S5, lane 3) . This finding shows that the rescue effect of the mutant initiator-tRNAs cannot be attributed to NMD, and reinforces the notion that SOS is likely distinct from NMD. Latent CAD mRNA transcribed from cDNA is relatively stable (Fig. S6) As can be seen in Fig. S6 (lanes 1,2) , the expression of latent CAD mRNA from the respective pre-spliced construct (psCAD-latent) gave rise to a relatively stable and easily detectable latent mRNA, whose steady-state level was comparable to the normally spliced mRNA expressed from psCAD-authentic. Comparable stabilities of the authentic and latent mRNAs expressed from psCAD-authentic and psCAD-latent, respectively, were also demonstrated by RT-PCR using primers that flank the latent exon (primer-pair a-b; Fig. S6, middle panel, lanes 1,2) . The amplified DNA bands were assigned to the respective mRNAs (and not to traces of the transfected DNA constructs), because no signal was obtained when the RNA was analyzed with primer-pair x-z, which flank the intron of both pre-mRNAs, only by PCR (Fig. S6 , upper panel, lanes 3,4).
Fig. S6
. CAD latent mRNA expressed from a pseudocDNA construct is stable. Schematic drawings of the CAD pre-mRNA and the mRNAs expressed from the authentic-, and latent-pseudo-cDNA constructs (psCADauthentic and psCAD-latent, respectively) are presented in Figure 4 . Top panel, lanes 1,2: RT-PCR analyses with primer-pair x-z of RNAs expressed from the indicated pseudo-cDNA constructs, demonstrating that both premRNAs underwent splicing. Lanes 3,4: Control PCR (no RT) demonstrating that the RNA preparation was free of DNA. Middle panel: Authentic-, and latent mRNAs (lanes1 and 2, respectively). (Table S1) We claim that SOS is distinct from NMD or any other nonsense RNA surveillance (degradation) mechanism. We have based this claim on a substantial number of experimental observations, which are summarized in the main manuscript and are listed in Table S1 . As can be seen, these data do not fit a model that could attribute the lack of latent splicing to a rapid and complete degradation of latent mRNAs by NMD (points I-III; V-IX) or by its hUpf1-dependent branches (point IV), or even by a yet unknown RNA surveillance mechanism (point X). They do, however, fit a mechanism that suppresses splicing involving latent alternative 5' splice sites whose usage could introduce an intronic stop codon into the resultant mRNA. In the present paper we show two additional experimental observations that cannot be interpreted as arising from rapid degradation by NMD or any RNA surveillance mechanism.
SI Discussion
IX. Expression of the mutant initiator tRNAs down-regulated the expression of the PTCcontaining latent mRNA. Interpreting this observation as arising from enhancement of NMD, or any RNA surveillance mechanism, contradicts our observation that expression of the mutant tRNAs up-regulated the expression of two bona fide PTC-containing NMD substrates. Namely, under our reaction conditions, NMD was abrogated rather than enhanced. X When the formation of latent mRNA was forced by expression from a pseudo cDNA construct, it was found to be relatively stable. Attributing the lack of latent splicing in cells grown under normal conditions to rapid degradation of the latent mRNA predicts that latent mRNA expressed from a prespliced (pseudo cDNA) construct, would be undetectable.
a (-), without treatment; (+), with treatment. b Observed expression of latent mRNA (i.e. RNA having an intronic in-frame stop codon upstream of a latent intronic 5' splice site). c Expected (and observed) occurrence of nonsense mRNA (i.e. RNA having an in-frame stop codon within a bona fide exon).
SI Methods
Plasmids. CAD-Mut31 (first ATG mutated to ACG) and CAD-Mut70 (first ATG mutated to AAA) were prepared from CAD-WT. IDUA-Mut30 (first ATG mutated to AAA) was prepared from IDUA-WT. The pseudo cDNA constructs, psCAD-authentic and psCAD-latent, were synthesized by Genscript Corporation, Piscatway, NJ, USA. The anti-codon of pTRM was mutated to generate the mutant initiator-tRNAs: Met- Transfections and RNA isolation and analyses. Human 293T cells were grown to 20-40% confluency in tissue culture plates and transiently co-transfected (6) with the appropriate constructs as described (1, 2) . Transfections with plasmids expressing tRNAs were at 5 µg per 5X10 6 cells. Cells were harvested at 24 h (CAD) or 48 h (IDUA) post transfection and total cellular RNA was extracted with guanidinium thiocyanate as described (2) . Treatment with actinomycin D of half confluent cell cultures was at 1 µg/ml of medium. RNA was extracted at time points as indicated and analyzed by real-time RT-PCR. For control, RNA was extracted from untreated cells. Northern blot analysis of U snRNAs was carried out as previously described (7), and tRNAs were analyzed with the following probes: Initiator-tRNA, 5'-TGGGCCCAGCACGCTT-3'; Lys-tRNA, 5'-TGGCGCCCGAACAGGGAC-3' (8); and MettRNA with the full-length reverse strand of the gene (5).
Quantitative real-time PCR (qPCR).
RT-PCR was performed as described (1, 2) . For quantitative real-time PCR analyses of CAD RNAs, amplification was carried out using three sets of specific primer-pairs, each enabling the amplification of a single specific product (premRNA, authentic mRNA or latent mRNAs) at a time (1) . Analogous pairs of specific primers were designed for the IDUA RNAs. Amplification was carried out using an ABI PRISM 7900 sequence detector (Applied Biosystem). For the amplification of IDUA RNAs, cDNA (2 µl of a 1:10 dilution) was mixed with 10 µl of 2X SYBR MIX (ABgene), the appropriate forward and reverse primers were added to 100 nM and DMSO concentration was adjusted to 5% in a final volume of 20 µl. The cycling conditions comprised 15 min of polymerase activation at 95°C, 40
cycles at 95°C for 20 sec, 62.5°C for 20 sec and 74°C for 30 sec. The amplification cycles were followed by a melting curve cycle. The final products were subjected to electrophoresis in 7.5%
polyacrylamide/7M urea gels to validate the production of a single amplicon per reaction. Each assay included (in duplicate) a no-template-control, and a mock-transfection RNA. The results represent at least three independent experiments (indicated in the legends to figures).
Data analysis. Data of the amplified splicing products corresponding to pre-mRNA, authentic mRNA, and latent mRNA, were exported as a tab-delimited text file to a Microsoft Excel spread sheet for further analysis. The amplification efficiency of the reference genes was determined by using the standard curve method and subsequently verified by linear regression method as described (9) Co-immunoprecipitation (co-IP) and Western blot analyses. Experiments were performed as described (10), using immobilized anti-Sm monoclonal antibodies (Mab Y12). Anti-Sm-bound complexes were eluted with 0.2 M glycine-HCl, pH 2.0, RNA was extracted with phenol from the bound and unbound fractions and analyzed by Northern blots. Proteins were precipitated from the water/phenol interphase of both fractions by adding 5 volumes of ethanol. For Western blots, total proteins were analyzed by 6% SDS/PAGE, blotted, and probed with antibodies against 4E-BP1 (provided by Dr. N. Sonenberg), GFP, Sm and α-tubulin as described (1, 10) . As control we used immobilized normal rabbit serum.
